Crossmark

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

Published Online: 2024-07-10

Authors

Honig, Lawrence S.

Sabbagh, Marwan N.

van Dyck, Christopher H.

Sperling, Reisa A.

Hersch, Steven

Matta, Andre

Giorgi, Luigi

Gee, Michelle

Kanekiyo, Michio

Li, David

Purcell, Derk

Dhadda, Shobha

Irizarry, Michael

Kramer, Lynn
License Information

Text and Data Mining valid from 2024-07-10

Version of Record valid from 2024-07-10
More Information

Article History

First Online: 10 July 2024

Document is current